Filing Details
- Accession Number:
- 0001181431-10-024530
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-05 13:00:00
- Reporting Period:
- 2010-05-03
- Filing Date:
- 2010-05-05
- Accepted Time:
- 2010-05-05 15:56:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1385830 | Neurogesx Inc | NGSX | Pharmaceutical Preparations (2834) | 943307935 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1367381 | Sv Life Sciences Fund Iv Lp | 60 State Street, Suite 3650 Boston MA 02109 | No | No | Yes | No | |
1392309 | P L Partners Strategic Iv Fund Sciences Life Sv | 60 State Street, Suite 3650 Boston MA 02109 | No | No | Yes | No | |
1422339 | Svlsf Iv, Llc | 60 State Street, Suite 3650 Boston MA 02109 | No | No | Yes | No | |
1422340 | Sv Life Sciences Fund Iv (Gp), L.p. | 60 State Street, Suite 3650 Boston MA 02109 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-05-03 | 291,718 | $10.25 | 2,159,991 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-05-03 | 8,282 | $10.25 | 61,324 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- These shares were sold by SV Life Sciences Fund IV, L.P. ("SVLS IV LP"). SV Life Sciences Fund IV (GP), L.P. ("SVLS IV GP"), the general partner of SVLS IV LP, may be deemed to have voting and dispositive power over the securities held by SVLS IV LP. SVLSF IV, LLC, the general partner of SVLS IV GP, may be deemed to have voting and dispositive power over the securities held by SVLS IV LP. Each of SVLS IV GP and SVLSF IV, LLC disclaims beneficial ownership of securities held by SVLS IV LP except to the extent of any pecuniary interest therein. SVLS IV LP and SV Life Sciences Fund IV Strategic Partners, L.P. ("Strategic Partners") (each a "Fund", or collectively the "Funds") may be deemed to beneficially own the securities held by each other Fund because of certain contractual relationships among the Funds and their affiliates. The Funds disclaim beneficial ownership of securities held by any other Fund except to the extent of any pecuniary interest therein.
- These shares were sold by Strategic Partners. SVLS IV GP, the general partner of Strategic Partners, may be deemed to have voting and dispositive power over the securities held by Strategic Partners. SVLSF IV, LLC, the general partner of SVLS IV GP, may be deemed to have voting and dispositive power over the securities held by Strategic Partners. Each of SVLS IV GP and SVLSF IV, LLC disclaims beneficial ownership of securities held by Strategic Partners except to the extent of any pecuniary interest therein. Each Fund may be deemed to beneficially own the securities held by each other Fund because of certain contractual relationships among the Funds and their affiliates. The Funds disclaim beneficial ownership of securities held by any other Fund except to the extent of any pecuniary interest therein.